Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective

Table 4

Resource use and unit costs.

Resource	Cost	Frequency	Source
Hip fracture
Year 1	$28,112	—	Brenneman et al. 2013 [39]
Year 2+	$9,734	—	Tosteson et al. 2008 [40]
Vertebral fracture
Year 1	$7,882	—	Brenneman et al. 2013 [39]
NHNV fracture	$9,236	—	Brenneman et al. 2013 [39]
Nursing home (per day)	$236	—	Brenneman et al. 2013 [39]
BMD measurement	$243	Once every 2 years	Physician’s Fee and Coding Guide 2013 [41]
Physician visit	$100	Once per year	Physician’s Fee and Coding Guide 2013 [41]
Intravenous (IV) injection	$151	Once per year (zoledronate only)	Physician’s Fee and Coding Guide 2013 [41]
Nurse visit	$42	Twice per year (denosumab only)	Physician’s Fee and Coding Guide 2013 [41]
Denosumab (yearly)	$1,650	—	EncoderPro.com WAC 2013 [42]
Generic alendronate (yearly)	$30	—	EncoderPro.com WAC 2013 [42]
Zoledronate (yearly)	$1,084	—	EncoderPro.com WAC 2013 [42]
Risedronate (yearly)	$1,708	—	EncoderPro.com WAC 2013 [42]
Ibandronate (yearly)	$1,332	—	EncoderPro.com WAC 2013 [42]
Teriparatide (yearly)	$14,514	—	EncoderPro.com WAC 2013 [42]

All costs have been inflated to 2013 USD where necessary.